Related Experiment Video

Updated: May 25, 2026

Knee Arthrocentesis in Adults
04:41

Knee Arthrocentesis in Adults

Published on: February 25, 2022

Systemic arthritis in children: a review of clinical presentation and treatment

R Gurion1, T J A Lehman, L N Moorthy

  • 1Division of Pediatric Rheumatology, Rainbow Babies & Children's Hospital, University Hospitals Case Medical Center, 11100 Euclid Avenue, Cleveland, OH 44106, USA.

International Journal of Inflammation
|January 12, 2012
PubMed

Insights

Systemic juvenile idiopathic arthritis (sJIA), a severe form of JIA, has a high mortality rate. Advances in understanding its autoinflammatory nature and new biologic therapies have significantly improved outcomes for affected children.

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Autoinflammatory Diseases

Background:

  • Systemic juvenile idiopathic arthritis (sJIA) is a rare but severe subtype of juvenile idiopathic arthritis (JIA).
  • sJIA is characterized by a disproportionately high mortality rate compared to other JIA subtypes.
  • It is increasingly recognized as a multifactorial autoinflammatory disease.

Purpose of the Study:

  • To provide a comprehensive review of systemic juvenile idiopathic arthritis (sJIA).
  • To cover epidemiology, pathogenesis, genetics, clinical features, complications, treatment, and prognosis.
  • To highlight recent advancements in understanding and managing sJIA.

Main Methods:

  • Literature review and synthesis of existing research on sJIA.
  • Analysis of epidemiological data, pathogenetic mechanisms, and genetic factors.
  • Evaluation of clinical manifestations, therapeutic strategies, and patient outcomes.

Main Results:

  • Clinical presentation of sJIA has remained consistent over decades.
  • Understanding of sJIA pathogenesis has significantly evolved.
  • Development of targeted therapies, especially biologic agents, has transformed disease management.

Conclusions:

  • Despite consistent clinical features, the improved understanding of sJIA pathogenesis is crucial.
  • New targeted therapies, particularly biologics, have markedly improved the prognosis and outcomes for children with sJIA.
  • sJIA remains a significant challenge requiring continued research and therapeutic innovation.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.